Episurf Medical announced the first Episealer® surgery in the U.S. The surgery was performed within the company’s Investigational Device Exemption (IDE) clinical trial, EPIC-Knee: Episealer Knee System IDE Clinical Study.
“This is, of course, a great milestone for us, and we would like to extend our gratitude to everyone involved. Many more surgeries are to come in the US, but the first surgery in the US is a special milestone for us,” said Pål Ryfors, CEO of Episurf Medical.
Episurf Medical announced the first Episealer® surgery in the U.S. The surgery was performed within the company's Investigational Device Exemption (IDE) clinical trial, EPIC-Knee: Episealer Knee System IDE Clinical Study.
"This is, of course, a great milestone for us, and we would like to extend our...
Episurf Medical announced the first Episealer® surgery in the U.S. The surgery was performed within the company’s Investigational Device Exemption (IDE) clinical trial, EPIC-Knee: Episealer Knee System IDE Clinical Study.
“This is, of course, a great milestone for us, and we would like to extend our gratitude to everyone involved. Many more surgeries are to come in the US, but the first surgery in the US is a special milestone for us,” said Pål Ryfors, CEO of Episurf Medical.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
